CME Cme Group Inc

  1. Stocks
  2. Financial Services
  3. NASDAQ: CME

Price (delayed)

$200.54

Market cap

$72.21B

P/E Ratio

22.81

Dividend/share

$9.75

EPS

$8.79

Enterprise value

$168.67B

CME Group Inc. is a global markets company. It is the world's largest financial derivatives exchange, and trades in asset classes that include agricultural products, currencies, energy, interest rates, metals, ...

Highlights
CME's P/E is 20% below its 5-year quarterly average of 28.4 and 4.3% below its last 4 quarters average of 23.7
The EPS is up by 12% year-on-year
The debt has declined by 26% year-on-year but it has grown by 4.6% since the previous quarter
Sector: Financial Services
Industry: Financial Data & Stock Exchanges
Website: https://www.cmegroup.com/
Peers: MSCI ICE CBOE NDAQ

Key stats

What are the main financial stats of CME
Market
Shares outstanding
360.06M
Market cap
$72.21B
Enterprise value
$168.67B
Valuations
Price to earnings (P/E)
22.81
Price to book (P/B)
2.66
Price to sales (P/S)
12.81
EV/EBIT
39.5
EV/EBITDA
36.52
EV/Sales
29.98
Earnings
Revenue
$5.63B
EBIT
$4.27B
EBITDA
$4.62B
Free cash flow
$3.36B
Per share
EPS
$8.79
Free cash flow per share
$9.36
Book value per share
$75.43
Revenue per share
$15.66
TBVPS
$282.25
Balance sheet
Total assets
$132.05B
Total liabilities
$104.9B
Debt
$97.9B
Equity
$27.15B
Working capital
$1.21B
Liquidity
Debt to equity
3.61
Current ratio
1.01
Quick ratio
1.01
Net debt/EBITDA
20.88
Margins
EBITDA margin
82.1%
Gross margin
100%
Net margin
56.8%
Operating margin
61.9%
Efficiency
Return on assets
2.3%
Return on equity
11.5%
Return on invested capital
4.1%
Return on capital employed
11.9%
Return on sales
75.9%
Dividend
Dividend yield
4.86%
DPS
$9.75
Payout ratio
110.9%

CME stock price

How has the Cme Group stock price performed over time
Intraday
0.58%
1 week
0.35%
1 month
2.74%
1 year
0.9%
YTD
-4.78%
QTD
2%

Financial performance

How have Cme Group's revenue and profit performed over time
Revenue
$5.63B
Gross profit
$5.63B
Operating income
$3.48B
Net income
$3.2B
Gross margin
100%
Net margin
56.8%
The operating income is up by 13% YoY
The company's net income rose by 12% YoY
CME's revenue is up by 10% year-on-year
The gross profit has increased by 10% YoY

Growth

What is Cme Group's growth rate over time

Valuation

What is Cme Group stock price valuation
CME P/E details
P/E
22.81
P/B
2.66
P/S
12.81
EV/EBIT
39.5
EV/EBITDA
36.52
EV/Sales
29.98
CME's P/E is 20% below its 5-year quarterly average of 28.4 and 4.3% below its last 4 quarters average of 23.7
The EPS is up by 12% year-on-year
CME's price to book (P/B) is 2.2% lower than its last 4 quarters average of 2.7
The P/S is 10% lower than the 5-year quarterly average of 14.1 and 5% lower than the last 4 quarters average of 13.4
CME's revenue is up by 10% year-on-year

Efficiency

How efficient is Cme Group business performance
The ROIC has soared by 52% YoY and by 8% from the previous quarter
Cme Group's return on assets has increased by 44% YoY and by 4.5% QoQ
Cme Group's return on equity has increased by 13% YoY

Dividends

What is CME's dividend history
Dividend details
DPS
$9.75
Dividend yield
4.86%
Payout ratio
110.9%
Recent dividends

Financial health

How did Cme Group financials performed over time
Cme Group's total assets is 26% more than its total liabilities
Cme Group's total liabilities has decreased by 24% YoY
Cme Group's total assets has decreased by 20% YoY
The debt has declined by 26% year-on-year but it has grown by 4.6% since the previous quarter
The debt to equity has contracted by 25% YoY but it has grown by 3.1% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.